Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-07-001528
Filing Date
2007-03-12
Accepted
2007-03-09 21:32:32
Documents
13
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 ALTUS PHARMACEUTICALS, INC. b63667ale10vk.htm 10-K 1806299
2 EX-3.1 RESTATED CERTIFICATES OF INCORPORATION OF THE REGISTRANT b63667alexv3w1.txt EX-3.1 38153
3 EX-10.4 2002 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN b63667alexv10w4.txt EX-10.4 65012
4 EX-10.9 DIRECTOR COMPENSATION POLICY DATED FEBRUARY 2, 2007 b63667alexv10w9.txt EX-10.9 8212
5 EX-10.13 AGREEMENT BETWEEN LAUREN SABELLA, DATED APRIL 4, 2006 b63667alexv10w13.txt EX-10.13 4345
6 EX-10.14 AGREEMENT BETWEEN BURKHARD BLANK, DATED JUNE 2, 2006 b63667alexv10w14.txt EX-10.14 4066
7 EX-10.15 AGREEMENT BETWEEN JOHN SORVILLO, DATED JULY 31, 2006 b63667alexv10w15.txt EX-10.15 3227
8 EX-10.16 AGREEMENT BETWEEN RENATO FUCHS, DATED AUGUST 14, 2006 b63667alexv10w16.txt EX-10.16 6231
9 EX-10.17 AGREEMENT BETWEEN BRUCE LEICHER, DATED OCTOBER 31, 2006 b63667alexv10w17.txt EX-10.17 3995
10 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM b63667alexv23w1.htm EX-23.1 1398
11 EX-31.1 SECTION 302 CERTIFICATION OF C.E.O. b63667alexv31w1.htm EX-31.1 6439
12 EX-31.2 SECTION 302 CERTIFICATION OF C.F.O. b63667alexv31w2.htm EX-31.2 5514
13 EX-32.1 SECTION 906 CERTIFICATION OF C.E.O. AND C.F.O. b63667alexv32w1.htm EX-32.1 5380
  Complete submission text file 0000950135-07-001528.txt   1959690
Mailing Address 125 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 125 SIDNEY STREET CAMBRIDGE MA 02139 617-299-2900
Altus Pharmaceuticals Inc. (Filer) CIK: 0001340744 (see all company filings)

EIN.: 043573277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51711 | Film No.: 07685985
SIC: 2836 Biological Products, (No Diagnostic Substances)